11:05 a.m.   

Validating the New Criteria: Lessons Learned from Cardiovascular Disease and Cholesterol

•   Explore challenges and lessons learned in the validation of cholesterol as a biomarker

•   Identify lessons learned that could be applied in the validation of AD guidelines

ROBERT MAHLEY
Senior Investigator
Gladstone Institute of Cardiovascular Disease and Neurological Disease
University of California, San Francisco

        
11:45 a.m.   

Panel Discussion: Identifying Principle Strategies for Validation of New Criteria

•   Identify a set of core principles that can be used to validate the newly proposed diagnostic criteria guidelines for symptomatic pre-dementia and dementia AD

•   Discuss next steps and strategies for moving forward

images   Examine the types of studies needed, their design and execution

WILLIAM THIES, Moderator
Chief Medical and Scientific Officer
Alzheimer’s Association

MONIQUE BRETELER
Professor
German Center for Neurodegenerative Diseases

DAVID BROOKS
Professor, Imperial College
Chief Medical Officer, GE Healthcare

CHARLES DeCARLI
Director
Alzheimer’s Disease Center
University of California, Davis



The National Academies | 500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement